The drug maker is seeking approval of a drug that treats people who have alreay contracted the disease.
As Covid-19 cases continue to surge in Michigan and the rest of the nation, drug maker Pfizer is seeking authorization of its medicine that treats people who have been infected with Covid-19.
The company says their pill treatment has shown to reduce hospitalizations and deaths among those who received the treatment. The company says their testing shows the drug reduces hospitalizations and deaths by 89%. That is dependent on the patient taking the drug within three days of showing symptoms.
Pfizer is naming the drug Paxlovid.
Drug maker Merk has already developed a similar pill and will undergo a review by a panel at the FDA in December.
12/20/24 - Delivery Deadlines for Christmas Packages and Letters
12/18/24 - Luna Fetches Top Dog Name in Ottawa County
12/13/24 - The Red Kettle Campaign is Getting a Boost
12/10/24 - Governor Signs Road Laws
